Amanote Research
Register
Sign In
Monotherapy Versus Combination Therapy for the Treatment of Pseudomonas Aeruginosa in Cystic Fibrosis Patients
Journal of Antibiotics Research
doi 10.15744/2574-5980.2.105
Full Text
Open PDF
Abstract
Available in
full text
Date
June 1, 2018
Authors
Alkhoury R
Kinkar E
Nokhbeh R
Saleh MT
Publisher
Annex Publishers, LLC
Related search
Treatment of Pseudomonas Aeruginosa Colonisation in Cystic Fibrosis.
Archives of Disease in Childhood
Child Health
Pediatrics
Perinatology
Immunization of Noncolonized Cystic Fibrosis Patients Against Pseudomonas Aeruginosa
Journal of Infectious Diseases
Infectious Diseases
Allergy
Immunology
Eradication of Pseudomonas Aeruginosa in Cystic Fibrosis
European Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
The Susceptibility of Pseudomonas Aeruginosa Strains From Cystic Fibrosis Patients to Bacteriophages
PLoS ONE
Multidisciplinary
Pseudomonas Aeruginosa in Cystic Fibrosis: A Chronic Cheater
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Low Rates of Pseudomonas Aeruginosa Misidentification in Isolates From Cystic Fibrosis Patients
Journal of Clinical Microbiology
Microbiology
Initial Pseudomonas Aeruginosa Treatment Failure Is Associated With Exacerbations in Cystic Fibrosis
Pediatric Pulmonology
Child Health
Pulmonary
Pediatrics
Perinatology
Respiratory Medicine
Antibiotic Perturbation of Mixed-Strain Pseudomonas Aeruginosa Infection in Patients With Cystic Fibrosis
BMC Pulmonary Medicine
Pulmonary
Respiratory Medicine
Bacteriophage-Based Therapy in Cystic Fibrosis-Associated Pseudomonas Aeruginosa Infections: Rationale and Current Status
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science